Concepedia

Michael Andreff

MA

Statistics

Publications

3

Citations

151

H-Index

3

Active since

1996

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Michael Andreff is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematologic malignancy therapy, and hematology.

Publications per year

1996–2016

3

Publications

3

Clinical implications of <i>TP53</i> mutations in myelodysplastic syndromes treated with hypomethylating agents

Koichi Takahashi, Keyur P. Patel, Carlos E. Bueso‐Ramos et al. · Oncotarget · 2016 · 106 citations · Full text

, , +17

Soluble FAS (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromes.

Reinhold Munker, Gregory P. Midis, Laurie B. Owen‐Schaub et al. · PubMed · 1996 · 27 citations

, , +11

Combined Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) Is Active for Relapsed and Refractory Patients with CLL.

William G. Wierda, Stefan Faderl, Susan O’Brien et al. · Blood · 2004 · 18 citations

, , +12

1–3 of 3